Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 47

Sort by

Sort Order Select

Journal Articles

CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis

Joseph M. Rocco, Joseph H. Oved, Rikita J Patel, A Zara Herskovits, Namitha Nair, Bita Shakoory, Thomas Robertson, Rachel Dileo, Max W Jacobs, Christa Zerbe, Rachael Gordon, Michael Joseph Ombrello, Amanda K Ombrello, Nirali N Shah, Dimana Dimitrova, Jennifer A Kanakry, Andrew D. Zelenetz, Alison J Moskowitz, Robert N Stuver, Zachary D Epstein-Peterson, Paola Ghione, Elena Mead, Zainab Shahid, Sergio A. Giralt, Sandeep S Raj, Jae H Park, Ivan Maillard, Mark B. Geyer, Wenbin Xiao, Ahmet Dogan, Megan S Lim, Jeffrey I. Zwicker, Jodi V. Mones, Rehka Parameswaran, Lauren G Banaszak, Shamir Geller, Bianca D. Santomasso, Roni Shouval, Kevin J. Curran, Ottavia M Delmonte, Luigi D Notarangelo, Jeffrey I Cohen, Steven M. Holland, Gilles A. Salles, Steven M Horwitz, Santosha A Vardhana, Miguel-Angel Perales, Daniella Schwartz, Irini Sereti, William T. Johnson

Blood blood.2025030976.

https://doi.org/10.1182/blood.2025030976

Published: 2025

Includes: Supplemental data

Journal Articles

Rethinking disparity in Acute Myeloid Leukemia, a new perspective in the Asian population

Agomoni Saha, Andriy Derkach, Wenbin Xiao, Eytan Stein, Ying Liu, Xin Wang

Blood (2025) 146 (Supplement 1): 38.

https://doi.org/10.1182/blood-2025-38

Published: 2025

Journal Articles

CXCL9 is a predictive biomarker of survival with IFNγ-targeted therapy in adult HLH patients

William Johnson, Joseph Rocco, Rikita Patel, Adrianna Herskovits, Elena Mead, Jae Park, Alison Moskowitz, Zachary Epstein-Peterson, Robert Stuver, Neil Bapodra, Rabeya Molla, Andrew Intlekofer, Jennifer Lue, Lia Palomba, Ariela Noy, Jasmine Zain, Colette Owens, Lynnette Henshaw, Paola Ghione, Efrat Luttwak, Pallawi Torka, Andrew Zelenetz, Philip Caron, Anita Kumar, Lorenzo Falchi, Natasha Galasso, Paul Hamlin, Alexander Boardman, Kevin David, Raphael Steiner, Nivetha Ganesan, Tiffany Chang, Zainab Shahid, Wenbin Xiao, Annamaria Ballweg, Alina Markova, Mark Geyer, Lauren Banaszak, Roni Shouval, Sergio Giralt, Gregory Goldgof, Jodi Mones, Jeffrey Zwicker, Rekha Parameswaran, Avi Leader, Cy R. Wilkins, Simon Mantha, Jeffrey Cohen, Jessica Durkee-Shock, Matthew Sedlock, Bita Shakoory, Irini Sereti, Miguel-Angel Perales, Gilles Salles, Santosha Vardhana, Joseph Oved, Steven Horwitz

Blood (2025) 146 (Supplement 1): 2996.

https://doi.org/10.1182/blood-2025-2996

Published: 2025

Journal Articles

A multi-site break through cancer pilot study testing the feasibility and safety of therapeutic intervention for patients with high-risk clonal cytopenia of undetermined significance (CCUS)

Danielle Hammond, Amy DeZern, Kelly Chien, Sanam Loghavi, Geoffrey Fell, Darren Evanchuk, Eytan Stein, Sam Sadigh, Rena Xian, Wenbin Xiao, Guillermo Garcia-Manero, Max Stahl, Lachelle Weeks

Blood (2025) 146 (Supplement 1): 3160.

https://doi.org/10.1182/blood-2025-3160

Published: 2025

Journal Articles

Unifying the classification of acute myeloid leukemia, myelodysplasia-related: A multi-institutional experience

Ying Liu, Derek Loneman, Brenden Bready, David Nemirovsky, Xin Wang, Eytan Stein, Andriy Derkach, Robert Hasserjian, Wenbin Xiao

Blood (2025) 146 (Supplement 1): 219.

https://doi.org/10.1182/blood-2025-219

Published: 2025

Journal Articles

Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype

Blood (2025) 145 (18): 2056–2069.

https://doi.org/10.1182/blood.2024026273

Published: 2025

Includes: Supplemental data

Journal Articles

Adult AML Patients with NUP98 Fusions Are Frequently Therapy-Related, and Are Associated with Monocytic Differentiation, Recurring Mutations in NRAS , DNMT3A and WT1 and Poor Outcome

Jinjuan Yao, Umut Aypar, Shenon Sethi, Leora Boussi, Dory Londono, Purvil Sukhadia, Ellin Berman, Eytan M. Stein, Ahmet Dogan, Wenbin Xiao, Yanming Zhang

Blood (2024) 144 (Supplement 1): 1556.

https://doi.org/10.1182/blood-2024-203634

Published: 2024

Journal Articles

A Multi-Site Break through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib (Trial In Progress)

Blood (2024) 144 (Supplement 1): 4265.2.

https://doi.org/10.1182/blood-2024-201582

Published: 2024

Journal Articles

Crebbp Inhibition Potentiates JAK2 Inhibition in Post-MPN Acute Myeloid Leukemia

Kalay Bertulfo, Hannah Miller, Ryan Najac, Juan Carlos Castelan, Cindy Ma, Koen Debackere, Wenbin Xiao, Raajit Rampal, Ross L Levine, Chao Lu, Adolfo A. Ferrando, Teresa Palomero

Blood (2024) 144 (Supplement 1): 823.

https://doi.org/10.1182/blood-2024-201988

Published: 2024

Journal Articles

Patients with AML and an IDH2-R172 Mutation Exhibit a Unique Response to Intensive Induction Chemotherapy, Suggesting Futility of Mid-Cycle Bone Marrow Biopsy and Caution When Considering Re-Induction

Meira Yisraeli Salman, Alexander R. Terry, Andriy Derkach, David Nemirovsky, Kuo-Kai Chin, Yannis K. Valtis, Leora Boussi, Theresa Spivey, Wenbin Xiao, Christopher Famulare, Jenna Ciervo, Jacob M. Rowe, Martin S. Tallman, Eytan M. Stein

Blood (2024) 144 (Supplement 1): 2847.

https://doi.org/10.1182/blood-2024-193242

Published: 2024

Journal Articles

“Ring-form” megakaryocytic dysplasia in STAG2 -mutated myelodysplastic neoplasm

Pratik Q. Deb, Wenbin Xiao

Blood (2024) 143 (21): 2218.

https://doi.org/10.1182/blood.2024024069

Published: 2024

Journal Articles

Cumulative Incidence of Myeloid Neoplasms in Patients with Nodal T-Follicular Helper Cell Lymphoma

Robert Stuver, Nivetha Ganesan, Ahmet Dogan, Zachary D. Epstein-Peterson, Paola Ghione, William Johnson, Natasha Lewis, Alison Moskowitz, Gunjan L. Shah, Michael Scordo, Wenbin Xiao, Steven M. Horwitz

Blood (2023) 142 (Supplement 1): 4438.

https://doi.org/10.1182/blood-2023-182272

Published: 2023

Journal Articles

Precision Lineage Deconvolution in Mixed Phenotype Acute Leukemia Using Cite-Seq Derived Hematopoietic Stages Identifies Lineage Dynamics Associated with Treatment Response

Deepika Dilip, Pallavi Galera, David Nemirovsky, Morgan Lallo, Kamal Menghrajani, Andriy Derkach, Ross L Levine, Richard Koche, Wenbin Xiao, Jacob Glass

Blood (2023) 142 (Supplement 1): 4324.

https://doi.org/10.1182/blood-2023-188871

Published: 2023

Journal Articles

Polytypic B-Cells, B-Cell Lymphoproliferative Disorders/Lymphomas, and Neoplastic T-Cells Divergently Differentiate from TET2 -/ DNMT3A -Mutated Clonal Hematopoiesis in Patients with Follicular Helper T-Cell Lymphomas/Lymphoproliferative Disorders

Natasha Lewis, Kseniya Petrova-Drus, Rohan Sardana, Qi Gao, Shenon Sethi, Wenbin Xiao, Mikhail Roshal, Jeeyeon Baik, Himanshu Bhurtel, Alison Moskowitz, Steven M. Horwitz, Ahmet Dogan

Blood (2023) 142 (Supplement 1): 849.

https://doi.org/10.1182/blood-2023-187320

Published: 2023

Journal Articles

CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis

Blood (2023) 141 (20): 2508–2519.

https://doi.org/10.1182/blood.2022015418

Published: 2023

Includes: Supplemental data

Journal Articles

Primary thymic marginal zone lymphoma with amyloidosis

Krasimira A. Rozenova, Wenbin Xiao

Blood (2023) 141 (12): 1494.

https://doi.org/10.1182/blood.2022019001

Published: 2023

Journal Articles

Erythroid and Megakaryocytic Differentiation Program in JAK2 -Mutated Acute Myeloid Leukemia with or without Antecedent Myeloproliferative Neoplasm

Blood (2022) 140 (Supplement 1): 9160–9162.

https://doi.org/10.1182/blood-2022-169215

Published: 2022

Journal Articles

Jak2 V617F Reversible Activation Shows an Essential Requirement for Jak2 V617F in Myeloproliferative Neoplasms (MPNs)

Blood (2022) 140 (Supplement 1): 803–804.

https://doi.org/10.1182/blood-2022-164827

Published: 2022

Journal Articles

Quantitative Cytogenetic Analysis with karyoParser Allows for More Precise Identification of Disease Biology, Clonal Evolution, and Etiology of Relapse in Acute Myeloid Leukemia

Deepika Dilip, Andriy Derkach, Kamal Menghrajani, Aaron D Goldberg, Hannah May, Virginia M. Klimek, Pallavi K Galera, Wenbin Xiao, Yanming Zhang, Olivier Elemento, Ross L. Levine, Jacob L Glass

Blood (2022) 140 (Supplement 1): 9119–9121.

https://doi.org/10.1182/blood-2022-170847

Published: 2022

Journal Articles

Single Cell Genotypic and Phenotypic Analysis of Measurable Residual Disease in Acute Myeloid Leukemia

Troy Robinson, Robert L. Bowman, Sonali Persaud, Ying Liu, Qi Gao, Jing-Ping Zhang, Xiaotian Sun, Adam Sciambi, Aaron Llanso, Christopher Famulare, Aaron D Goldberg, Ahmet Dogan, Mikhail Roshal, Ross L. Levine, Wenbin Xiao

Blood (2022) 140 (Supplement 1): 2275–2277.

https://doi.org/10.1182/blood-2022-166501

Published: 2022

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis

Rethinking disparity in Acute Myeloid Leukemia, a new perspective in the Asian population

CXCL9 is a predictive biomarker of survival with IFNγ-targeted therapy in adult HLH patients

A multi-site break through cancer pilot study testing the feasibility and safety of therapeutic intervention for patients with high-risk clonal cytopenia of undetermined significance (CCUS)

Unifying the classification of acute myeloid leukemia, myelodysplasia-related: A multi-institutional experience

Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype

Adult AML Patients with NUP98 Fusions Are Frequently Therapy-Related, and Are Associated with Monocytic Differentiation, Recurring Mutations in NRAS , DNMT3A and WT1 and Poor Outcome

A Multi-Site Break through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib (Trial In Progress)

Crebbp Inhibition Potentiates JAK2 Inhibition in Post-MPN Acute Myeloid Leukemia

Patients with AML and an IDH2-R172 Mutation Exhibit a Unique Response to Intensive Induction Chemotherapy, Suggesting Futility of Mid-Cycle Bone Marrow Biopsy and Caution When Considering Re-Induction

“Ring-form” megakaryocytic dysplasia in STAG2 -mutated myelodysplastic neoplasm

Cumulative Incidence of Myeloid Neoplasms in Patients with Nodal T-Follicular Helper Cell Lymphoma

Precision Lineage Deconvolution in Mixed Phenotype Acute Leukemia Using Cite-Seq Derived Hematopoietic Stages Identifies Lineage Dynamics Associated with Treatment Response

Polytypic B-Cells, B-Cell Lymphoproliferative Disorders/Lymphomas, and Neoplastic T-Cells Divergently Differentiate from TET2 -/ DNMT3A -Mutated Clonal Hematopoiesis in Patients with Follicular Helper T-Cell Lymphomas/Lymphoproliferative Disorders

CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis

Primary thymic marginal zone lymphoma with amyloidosis

Erythroid and Megakaryocytic Differentiation Program in JAK2 -Mutated Acute Myeloid Leukemia with or without Antecedent Myeloproliferative Neoplasm

Jak2 V617F Reversible Activation Shows an Essential Requirement for Jak2 V617F in Myeloproliferative Neoplasms (MPNs)

Quantitative Cytogenetic Analysis with karyoParser Allows for More Precise Identification of Disease Biology, Clonal Evolution, and Etiology of Relapse in Acute Myeloid Leukemia

Single Cell Genotypic and Phenotypic Analysis of Measurable Residual Disease in Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only